Monday, October 23, 2017

Clinical Trial To Study Effects Of Breast Ultrasound With Immunotherapy.

Aunt Minnie (10/23) reports that the University of Virginia Health System is “enrolling women diagnosed with stage IV metastatic breast cancer in a new clinical trial that will combine two therapies: focused ultrasound and a cancer immunotherapy drug, according to the Focused Ultrasound Foundation.” The article adds that participants “will receive noninvasive focused ultrasound therapy using Theraclion’s EchoPulse system to ablate part of the primary breast tumor or metastatic tumors and also doses of pembrolizumab (Keytruda, Merck).” Dr. David Brenin, one of the leaders of the study, said, “Focused ultrasound induces a local immune response and may have the ability to change that paradigm, enabling a medication like pembrolizumab to make a difference.” 

Author: Alan Boyce

Categories: 2017, October, News, Research and CareNumber of views: 6202